222 related articles for article (PubMed ID: 31127475)
1. Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield.
Wald K; Cakmak H; Mok-Lin E; Cedars M; Rosen M; Letourneau J
J Assist Reprod Genet; 2019 Jun; 36(6):1161-1168. PubMed ID: 31127475
[TBL] [Abstract][Full Text] [Related]
2. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation.
İsrafilova G; Şükür YE; Özkavukcu S; Sönmezer MA; Atabekoğlu CS; Özmen B; Berker B; Aytaç R; Koç A; Sönmezer M
Reprod Sci; 2021 Aug; 28(8):2200-2207. PubMed ID: 33409878
[TBL] [Abstract][Full Text] [Related]
4. Random-start ovarian stimulation in patients with cancer.
Cakmak H; Rosen MP
Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
[TBL] [Abstract][Full Text] [Related]
5. Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved.
Filippi F; Martinelli F; Paffoni A; Reschini M; Raspagliesi F; Somigliana E
J Assist Reprod Genet; 2019 Mar; 36(3):569-578. PubMed ID: 30478807
[TBL] [Abstract][Full Text] [Related]
6. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
[TBL] [Abstract][Full Text] [Related]
7. Fertility preservation with random-start controlled ovarian stimulation and embryo cryopreservation for early pregnancy-associated breast cancer.
Pereira N; Kligman I; Hunt R; Kopparam R; Wahmann B; Rosenwaks Z
Gynecol Endocrinol; 2019 Mar; 35(3):214-216. PubMed ID: 30403906
[TBL] [Abstract][Full Text] [Related]
8. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.
Cakmak H; Katz A; Cedars MI; Rosen MP
Fertil Steril; 2013 Dec; 100(6):1673-80. PubMed ID: 23987516
[TBL] [Abstract][Full Text] [Related]
9. Ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts.
Alexander VM; Martin CE; Schelble AP; Laufer AB; Hardi A; McKenzie LJ; Hipp HS; Kawwass JF; Spencer JB; Jungheim ES
J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102080. PubMed ID: 33545413
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of random-start controlled ovarian stimulation in cancer patients.
Kim JH; Kim SK; Lee HJ; Lee JR; Jee BC; Suh CS; Kim SH
J Korean Med Sci; 2015 Mar; 30(3):290-5. PubMed ID: 25729252
[TBL] [Abstract][Full Text] [Related]
11. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
Muteshi C; Child T; Ohuma E; Fatum M
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
[TBL] [Abstract][Full Text] [Related]
12. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
13. Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients.
Campos APC; Geber GP; Hurtado R; Sampaio M; Geber S
JBRA Assist Reprod; 2018 Nov; 22(4):352-354. PubMed ID: 30264947
[TBL] [Abstract][Full Text] [Related]
14. Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases-an analysis of 992 stimulations.
von Wolff M; Bruckner T; Strowitzki T; Germeyer A
J Assist Reprod Genet; 2018 Sep; 35(9):1713-1719. PubMed ID: 29869766
[TBL] [Abstract][Full Text] [Related]
15. Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre.
Sahin G; Goker ENT; Gokmen E; Yeniay L; Acet F; Zekioglu O; Tavmergen E
J Obstet Gynaecol; 2022 Apr; 42(3):518-523. PubMed ID: 34382483
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation.
Huang H; Itaya Y; Samejima K; Ichinose S; Narita T; Matsunaga S; Saitoh M; Takai Y
J Ovarian Res; 2022 Jan; 15(1):2. PubMed ID: 34983605
[TBL] [Abstract][Full Text] [Related]
17. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy].
Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P
Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272
[TBL] [Abstract][Full Text] [Related]
18. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
19. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of ovarian stimulation after treatment with chemotherapy.
Chan JL; Johnson LN; Efymow BL; Sammel MD; Gracia CR
J Assist Reprod Genet; 2015 Oct; 32(10):1537-45. PubMed ID: 26400507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
